Erste Group Bank Has Positive Opinion of UNH FY2026 Earnings

Key Points

• Erste Group Bank raised its UnitedHealth Group FY2026 EPS estimate to $20.55 from $19.86 and issued a FY2027 estimate of $23.29. The bank maintained a “Hold” rating, while the broader analyst consensus is “Moderate Buy” with a $463.80 average price target.
• UnitedHealth recently reported quarterly EPS of $4.69, beating expectations of $4.14, while revenue of $112.70 billion also exceeded forecasts. Management’s FY2026 earnings guidance is approximately $20.50 per share.
• UNH shares opened at $425.29, and the company maintains a quarterly dividend of $2.32 per share, equivalent to a 2.2% annualized yield.

UnitedHealth Group Incorporated (NYSE:UNH - Free Report) - Stock analysts at Erste Group Bank raised their FY2026 earnings estimates for shares of UnitedHealth Group in a research report issued to clients and investors on Wednesday, October 21st. Erste Group Bank analyst H. Engel now forecasts that the healthcare conglomerate will post earnings of $20.55 per share for the year, up from their prior estimate of $19.86. Erste Group Bank has a "Hold" rating on the stock. The consensus estimate for UnitedHealth Group's current full-year earnings is $20.64 per share. Erste Group Bank also issued estimates for UnitedHealth Group's FY2027 earnings at $23.29 EPS.

Several other equities research analysts have also commented on the stock. Leerink Partners upped their price target on shares of UnitedHealth Group from $462.00 to $472.00 and gave the company an "outperform" rating in a research report on Friday, July 17th. Evercore boosted their target price on shares of UnitedHealth Group from $400.00 to $480.00 and gave the company an "outperform" rating in a research report on Tuesday, July 7th. Oppenheimer upped their target price on shares of UnitedHealth Group from $420.00 to $500.00 and gave the company an "outperform" rating in a report on Friday, July 17th. BMO Capital Markets set a $512.00 price target on shares of UnitedHealth Group in a research report on Tuesday, July 21st. Finally, Robert W. Baird cut their price objective on shares of UnitedHealth Group from $453.00 to $427.00 and set a "neutral" rating for the company in a research report on Wednesday, October 14th. Twenty investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and an average target price of $463.80.

UnitedHealth Group Stock Up 2.0%

UNH stock opened at $425.29 on Friday. The business's 50-day moving average is $388.15 and its two-hundred day moving average is $389.52. The company has a market cap of $381.73 billion, a price-to-earnings ratio of 24.29, a P/E/G ratio of 1.51 and a beta of 0.60. UnitedHealth Group has a fifty-two week low of $255.96 and a fifty-two week high of $461.62. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, beating the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The firm had revenue of $112.70 billion for the quarter, compared to analysts' expectations of $111.31 billion. During the same period in the prior year, the firm earned $2.59 EPS. The company's revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were paid a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group's dividend payout ratio (DPR) is currently 53.00%.

Insider Activity

In related news, CEO Patrick Conway sold 1,169 shares of the business's stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.19% of the company's stock.

Institutional Trading of UnitedHealth Group

Several institutional investors and hedge funds have recently made changes to their positions in the business. BlackRock Inc. lifted its holdings in UnitedHealth Group by 4.6% during the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate's stock valued at $31,946,594,000 after buying an additional 3,395,530 shares in the last quarter. State Street Corp boosted its position in UnitedHealth Group by 0.7% in the 2nd quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate's stock valued at $18,966,555,000 after buying an additional 301,081 shares during the period. Bank of New York Mellon Corp grew its stake in UnitedHealth Group by 6.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate's stock worth $4,449,317,000 after acquiring an additional 616,723 shares in the last quarter. Wellington Management Group LLP grew its stake in UnitedHealth Group by 5.8% in the 2nd quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate's stock worth $4,436,923,000 after acquiring an additional 583,536 shares in the last quarter. Finally, Corient Private Wealth LP increased its position in shares of UnitedHealth Group by 1,443.7% during the second quarter. Corient Private Wealth LP now owns 8,447,224 shares of the healthcare conglomerate's stock worth $3,510,920,000 after acquiring an additional 7,900,011 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Higher earnings estimates: Erste Group Bank raised its UnitedHealth EPS forecasts to $20.55 for fiscal 2026 from $19.86 and to $23.29 for fiscal 2027 from $22.51. The 2026 estimate is close to the $20.64 consensus, while the higher 2027 forecast signals confidence in continued earnings growth.
• Positive Sentiment: Improved operating performance: Recent coverage highlighted a roughly 61% year-over-year increase in adjusted third-quarter EPS, management’s higher full-year outlook and an 88.4% medical care ratio. A lower ratio indicates that UnitedHealth is retaining more premium revenue after paying medical costs. UnitedHealth's Earnings Jumped 60%. Is the Comeback Stock a Buy, Sell, or Hold?
• Positive Sentiment: More bullish valuation support: Mizuho raised its price target on UNH to $500 from $493 and maintained an “outperform” rating, implying meaningful upside from the referenced $425.29 level. Mizuho UnitedHealth recommendations
• Positive Sentiment: Operating leverage thesis: Analysts argue that efficiency gains and earnings growth could continue supporting the shares, while UnitedHealth’s Optum segment provides an additional earnings engine. UnitedHealth Group: Operating Leverage Should Continue Sending the Stock Higher
• Neutral Sentiment: Investor interest is elevated: UNH has attracted substantial Zacks user and Wall Street attention, although an average “Buy” rating may already reflect much of the positive outlook. UnitedHealth Group is Attracting Investor Attention
• Negative Sentiment: Cost and policy risks: UnitedHealth plans to raise 2027 Medicare costs for seniors. Medical inflation and Medicare funding pressure could weigh on margins across both insurance and Optum, while healthcare stocks also faced broader sector weakness. UnitedHealth Will Raise 2027 Medicare Costs for Seniors

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.